CCND2 and astrocytoma (excluding glioblastoma): Exploration of epigenetic regulation of Cyclin D2 in medulloblastomas and astrocytomas was motivated by previous studies which had revealed Cyclin D2 silencing in cancers such as breast [34], lung [35], and prostate [36], due to promoter hypermethylation.